|
|
|
Volumn 102, Issue 4 II, 1998, Pages 1064-1085
|
|
1997 USPHS/IDSA report on the prevention of opportunistic infections in patients infected with human immunodeficiency virus
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
AZITHROMYCIN;
CIDOFOVIR;
CIPROFLOXACIN;
CLARITHROMYCIN;
COTRIMOXAZOLE;
DAPSONE;
ETHAMBUTOL;
FLUCONAZOLE;
FOLINIC ACID;
FOSCARNET;
GANCICLOVIR;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HEPATITIS B VACCINE;
INFLUENZA VACCINE;
ISONIAZID;
ITRACONAZOLE;
KETOCONAZOLE;
LOPERAMIDE;
PENTAMIDINE;
PNEUMOCOCCUS VACCINE;
PYRAZINAMIDE;
PYRIDOXINE;
PYRIMETHAMINE;
RIFABUTIN;
RIFAMPICIN;
CANDIDIASIS;
CHEMOPROPHYLAXIS;
CRYPTOCOCCOSIS;
CRYPTOSPORIDIOSIS;
HEPATITIS B;
HISTOPLASMOSIS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTESTINE INFECTION;
MICROSPORIDIOSIS;
OPPORTUNISTIC INFECTION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RESPIRATORY TRACT INFECTION;
REVIEW;
RICKETTSIOSIS;
RISK FACTOR;
TERATOGENICITY;
TUBERCULOSIS;
VIRUS INFECTION;
|
|
EID: 0031656053
PISSN: 00314005
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (12)
|
|
References (24)
|
